Project Grant HT94252311012
Award Date
9/15/23
Completion Date
9/14/25
Dollars Obligated
$500K
Federal Agency
Defense Health Agency
Awardee
Xplosafe LLC (DDV1PJUEK2X9)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Stillwater, OK, USA
Similar Awards
The Defense Health Agency awarded Epicentrx Inc. a $385,536 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports the development and translation of a multimodal therapeutic agent and medical countermeasure for the treatment of military-related toxic exposures. The project will be conducted over a 3-year period from September 1, 2024 to August 31, 2027. The research aims to transform healthcare for military service members and...
This $775,000 Project Grant from the Defense Health Agency under the CFDA 12.420 Military Medical Research and Development program supports research at Wake Forest University Health Sciences (WFUHS) to model airborne hazard exposures using an airway-on-a-chip platform. The goal is to elucidate common pathophysiological mechanisms and identify potential medical countermeasure targets. This 3-year research project, starting on September 1, 2023, will leverage WFUHS's expertise in biomedical...
The Defense Health Agency awarded a $1,117,352 Project Grant to Trustees of Boston University's Boston University Medical Campus to develop a novel and practical intervention for detoxification of per- and polyfluoroalkyl substances (PFAS) in humans. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports the university's research to transform health care for Service Members and the public through innovative biomedical research. As part of the...
The federal Project Grant award, valued at $200,000.00 and awarded on Feb 26, 2025 by the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program, supports research at the Massachusetts Institute of Technology (MIT) to discover highly stable materials for adsorption and catalytic decontamination. The award will fund fundamental, applied, and advanced research at MIT aimed at advancing scientific knowledge and capabilities...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,857,470 Cooperative Agreement to The Geneva Foundation to develop a multiplex testing platform that can simultaneously detect and identify Plasmodium species infections. This platform will serve as both a diagnostic tool and an epidemiological surveillance tool. The project performance period is from June 1, 2024 to May 31, 2028. Under a $268,312 sub-award, Meso Scale...
This cooperative agreement, awarded by the Department of the Army Materiel Command Research Development and Engineering Command (RDECOM), supports the development of an advanced microwave-activated microporous material sensor for enhanced chemical threat detection in military helmets. The research is funded under the Department of Defense Basic Scientific Research program (CFDA 12.431), which aims to advance fundamental knowledge and technological capabilities with potential military...
The federal Project Grant award of $631,742.00 was made by the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction (CFDA 12.351) program. The objective is to develop color-changing coatings and bioengineered enzymes for the sensitive and specific colorimetric detection of vesicant chemical warfare agents on surfaces. This research aims to reduce personnel health risks and streamline decontamination protocols. The award was made to KRI At...
The Regents of the University of California, San Francisco will deliver a wearable sensor array for continuous real-time dosimetry for theranostics under a three-year, $1.45 million Project Grant from the Defense Health Agency. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative solutions for battlefield medicine. Specifically,...
The Defense Health Agency awarded Nushores Biosciences LLC a $582,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to develop an "Electrolysis Assisted Catalytic Oxygen Gas Generator for Battlefield Use". The grant, awarded on February 15, 2025, supports the company's research and development of an innovative medical technology designed to address critical needs in military environments. Nushores Biosciences LLC, a small for-profit limited...
This $729,778 federal Project Grant award, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. The 3-year award to the University of Wisconsin System, which commenced on June 1, 2025, will fund advanced research into transforming healthcare for military service members and the broader public through innovative scientific investigations...